###begin article-title 0
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme that plays a role in DNA repair, differentiation, proliferation, and cell death. The polymorphisms of PARP-1 have been associated with the risk of various carcinomas, including breast, lung, and prostate. We investigated whether PARP-1 polymorphisms are associated with the risk of non-Hodgkin lymphoma (NHL).
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Subjects from a Korean population consisting of 573 NHL patients and 721 controls were genotyped for 5 PARP-1 polymorphisms (Asp81Asp, Ala284Ala, Lys352Lys, IVS13+118A>G, and Val762Ala) using High Resolution Melting polymerase chain reaction (PCR) and an automatic sequencer.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
None of the 5 polymorphisms were associated with overall risk for NHL. However, the Val762Ala polymorphism was associated with reduced risk for NHL in males [odds ratio (OR), 0.62; 95% confidence interval (CI), 0.41-0.93 for CC genotype and OR, 0.84; 95% CI, 0.60-1.16 for TC genotype] with a trend toward a gene dose effect (p for trend, 0.02). The Asp81Asp (p for trend, 0.04) and Lys352Lys (p for trend, 0.03) polymorphisms revealed the same trend. In an association study of PARP-1 haplotypes, the haplotype-ACAAC was associated with decreased risk of NHL in males (OR, 0.75; 95% CI, 0.59-0.94).
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
The present data suggest that Val762Ala, Asp81Asp, and Lys352Lys polymorphisms and the haplotype-ACAAC in PARP-1 are associated with reduced risk of NHL in Korean males.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy worldwide. It represents 4% of cancers, and is the fifth commonly diagnosed cancer in the United States [1]. Its rates are over 10/100,000 in the United States, Australia, and Western Europe, while less than 5/100,000 in Southern and Eastern Asia [2].
###end p 10
###begin p 11
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
PARP-1 is a nuclear enzyme that catalyzes the poly(ADP-ribosyl)ation of target proteins in response to DNA damage; it is involved in DNA repair, cell death, proliferation, genome integrity, and modulation of gene transcription [3,4]. PARP-1 is involved in base excision reaction, which repairs DNA damage induced by chemical alterations, reactive oxidative species, and ionizing radiation. In addition, PARP-1 activation mediates apoptosis through the induction of translocation of apoptosis-inducing factor from the mitochondria to the nucleus [5].
###end p 11
###begin p 12
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp </italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53-</italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp</italic>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp-1 </italic>
###xml 850 853 850 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 875 881 875 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp-1</italic>
###xml 881 885 881 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 965 971 965 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp-1</italic>
###xml 971 975 971 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+ </sup>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1083 1090 1083 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1288 1290 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1293 1299 1293 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parp-1</italic>
###xml 1299 1303 1299 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1532 1539 1532 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1043 1048 <span type="species:ncbi:42554">tetra</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1485 1490 <span type="species:ncbi:9606">women</span>
The effect of PARP-1 on carcinogenesis is still unclear and controversial. PARP-1 activation has been reported to inhibit carcinogenesis by activation of DNA repair system [6-13]. Parp deficiencies have enhanced tumorigenesis and widened the tumor spectrum in p53-deficient mice [10]. Treatment with the alkylating agent, azoxymethane, enhanced the frequency of tumor development in the colon and liver of Parp-1-/- mice [9]. Studies have demonstrated that PARP-1 Val762Ala polymorphism is associated with an increased risk of carcinomas, including prostate [8], esophagus [7], lung [12], stomach [11], breast [13], and urinary bladder [6]. In contrast, others have reported that inhibition or the absence of PARP-1 is associated with reduced risk of malignancy by inducing tumor cell apoptosis [14-18]. Loss of Parp-1 has increased tumor latency in p53-deficient mice [14]. Parp-1-/- mice displayed a diminished susceptibility to skin carcinogenesis compared with Parp-1+/+ mice after treatment with 7,12-dimethylbenz [a]-anthracene and 12-O-tetra-decanoyl-phorbol-13-acetate [17]. PARP-1 polymorphisms have been associated with reduced risk of malignancy in several case-control studies [15,16,18]. However, others have also proposed that PARP-1 has no effects on tumor development [19,20]. Parp-1-/- mice did not demonstrate an increased incidence of tumor formation after either 4-nitroso-quinoline or 2-amino-3-methylimidazo treatment [19]. In a case-control study in Connecticut women, the risk of NHL was not associated with PARP-1 Val762Ala polymorphism [20].
###end p 12
###begin p 13
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
Although many studies have searched for the association between PARP-1 polymorphisms and the risk of malignancy, the results are inconsistent in different organs and in different ethnic groups. We performed a population-based, case-control study to identify the association between PARP-1 polymorphisms and NHL risk in Korean subjects.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study population
###end title 15
###begin p 16
###xml 427 429 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 574 576 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 773 775 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1152 1153 1144 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 940 948 <span type="species:ncbi:9606">patients</span>
This case-control study included NHL patients (n = 573) and cancer-free controls (n = 721). All cases and controls were unrelated Korean individuals; the cases were adults (median age at diagnosis +/- S.D 55.0 +/- 14.6 years, range 15.0-90.0 years), histologically diagnosed with NHL between 1997 and 2006 at Chonnam National University Hospital (Gwangju, Korea) or Chonnam National University Hwasun Hospital (Hwasun, Korea) [21]. Lymph nodes or extranodal tissues were obtained and histologically diagnosed according to the World Health Organization (WHO) classification [22]. A staging workup included physical examination, laboratory examination, computed tomography scan, bone marrow biopsy, and lumbar puncture. Stages were defined according to the Ann Arbor system [23]. Types of NHL included diffuse large B-cell lymphomas (n = 330), T-cell lymphomas (n = 122), and other lymphomas (n = 121). The controls were frequency matched to patients by age within 5 years, sex, and county of residence. All of the healthy controls have no history of cancer (427 males, 304 females; median age +/- S.D. 56.0 +/- 15.3 years, range 17.0-82.5 years) (Table 1). All cases and controls provided informed consent for study participation. The study was approved by the Institutional Review Board of the Chonnam National University Hwasun Hospital in Hwasun, Korea.
###end p 16
###begin p 17
Frequency distribution of selected characteristics of study subjects According to case-control status
###end p 17
###begin p 18
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
P values for differences in socio-demographic characteristics between cases and controls.
###end p 18
###begin p 19
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B </sup>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sup>
NA indicates not applicable. Marginal zone* includes marginal zone B-cell lymphoma (n = 12) and mucosa-associated lymphoid tissue (MALT) (n = 57). OthersB includes B-cell prolymphocytic leukemia (n = 1) and undetermined B-cell lymphoma (n = 11). OthersT includes all T-cell lymphoma (n = 67) except for peripheral T-cell lymphoma.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 294 296 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 972 973 963 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA was obtained from peripheral blood using a QIAamp DNA Blood Mini Kits (Qiagen, Valencia, CA, USA) according to the manufacturer's protocols. PCR cycling and high resolution melting (HRM) analysis was performed on the Rotor-Gene 6000trade mark (Corbett Research, Sydney, Australia) [24]. The PCR primers were as follows: for Val762Ala (86 bp fragment), 5'-taagtcgggggctttctttt-3' (forward), and 5'-agcagactgtaggccacctc-3' (reverse); for Asp81Asp (160 bp fragment), 5'-gatgggttctctgagcttcg-3' (forward), and 5'-gaggtttgctttgctctctga-3' (reverse); for Ala284Ala (76 bp fragment), 5'-gccctctgacatgtttctcc-3' (forward), and 5'-aaggagggcaccgaacac-3' (reverse); for Lys352Lys (178 bp fragment), 5'-caagggagagctggcttctt-3' (forward), and 5'-ggagttcacagcagcagga-3' (reverse); for IVS13+118A>G (124 bp fragment), 5'-tggatcaggtggcatcatag-3' (forward), and 5'-ggtactggccttcatgcaat-3' (reverse). The reaction mixture included genomic DNA (10 ng), 1x PCR buffer, 2.5 mM MgCl2, primers (100 nM), dNTPs (100 muM), SYTO 9 green fluorescent nucleic acid stain (2.5 muM; Invitrogen, Carlsbad, CA, USA), Taq. polymerase (0.5 U; Solgent, Daejeon, Korea) and water to a total volume of 10 mul. Cycling conditions included an initial 5 min hold at 95degreesC, followed by 40 cycles at 95degreesC for 5 s, annealing temperatures for 30 s, and 72degreesC for 20 s; a single cycle of 95degreesC for 1 s, 72degreesC for 90 s, and melting increasing from 70degreesC to 90degreesC at 0.1degreesC per second. Annealing temperatures for Asp81Asp, Ala284Ala, Lys352Lys, Val762Ala and IVS13+118A>G were 62degreesC, 56degreesC, 58degreesC, 56degreesC, and 60degreesC, respectively.
###end p 21
###begin p 22
PCR products were column-purified after HRM analysis using the PCR-M clean up kit (GeneAll Biotechnology, Seoul, Korea) according to the manufacturer's instructions. PCR products were eluted in a 20 mul volume, purified PCR products were used as templates in the Big Dye Terminator v3.1 Cycling Sequencing kit (Applied Biosystems, Foster City, CA, USA). The reaction mix consisted of 1x terminator pre-mix, 1x sequencing buffer, primers (667 nM), and purified template (1 mul) in a 10 mul total volume. Reactions were run on a PTC-100 thermal cycler (MJ Research, Reno, NV, USA) as follows: a single cycle of 95degreesC for 1 min, 25 cycles of 95degreesC for 10 s, 50degreesC for 5 s, and 60degreesC for 4 min. Sequencing reactions were ethanol-precipitated and run on a 3100 Genetic Analyser (Applied Biosystems). In 90 subjects, the results of HRM analyses were compared with those from cycle sequencing, and the resulting concordance rate was 100%.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 403 405 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 810 817 810 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
Hardy-Weinberg equilibrium testing was performed using the chi-square goodness-of-fit test. The Pearson chi-square test was used to examine the genotype distribution differences between cases and controls. Adjusted odds ratios (ORs) were calculated using a logistic regression model that controlled for gender and age and included 95% confidence intervals (CIs). Statistical significance was defined at p values less than 0.05, and all statistical tests were 2-sided. Haplotypes and haplotype frequencies were calculated using the SNPAnalyzer-Pro version 1.8 software (Istech, Goyang, Korea) to analyze associations between haplotypes and NHL risk after stratification by age at diagnosis, sex, and NHL subtype. All calculations were performed using an SPSS software package, version 13.0 (SPSS, Chicago, IL). PARP-1 inter-SNP linkage disequilibrium was calculated using Haploview software version 4.1  for the set of control samples (n = 721).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 132 134 132 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 278 280 278 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 301 303 301 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 349 351 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 820 821 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Characteristics of the study population are summarized in Table 1. There were no differences in the frequency distribution for age (p = 0.33) or sex (p = 0.77) between cases and controls. The control genotype distributions were in agreement with the Hardy-Weinberg equilibrium (p = 0.61 for Asp81Asp, p = 0.31 for Ala284Ala, p = 0.83 for Lys352Lys, p = 0.38 for IVS13+118 A>G, p = 0.84 for Val762Ala). Haploview version 4.1 determined that the PARP-1 locus contained 1 block of linkage disequilibrium (Figure. 1). Two groups of polymorphisms were present in the block; one group consisted of Asp81Asp, Lys352Lys, and Val762Ala polymorphism, and the other included Ala284Ala and IVS13+118A>G polymorphism. Both revealed high intra-group linkage disequilibrium (r2, >/= 0.96), but low inter-group linkage disequilibrium (r2, 0.22-0.23).
###end p 26
###begin p 27
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>PARP-1 </italic>inter-polymorphism linkage disequilibrium</bold>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
PARP-1 inter-polymorphism linkage disequilibrium. PARP-1 inter-polymorphism linkage disequilibrium. r2 between pairs of polymorphisms was calculated based on all the controls using Haploview v4.1 .
###end p 27
###begin p 28
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
Table 2 summarizes the association study between the 5 polymorphisms and the overall risk for NHL. Analysis revealed no significant associations between polymorphisms and overall NHL risk. Neither the CC genotype of Val762Ala (OR, 0.85; 95%CI, 0.62-1.17) nor the TC genotype (OR, 0.93; 95%CI, 0.72-1.19) were associated with risk for NHL. The genotypes of the remaining 4 polymorphisms were also associated with risk for NHL.
###end p 28
###begin p 29
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
Association testing of PARP-1 polymorphisms with risk of NHL
###end p 29
###begin p 30
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
All analyses have been age- and sex-adjusted. P values were > 0.05 in all analyses.
###end p 30
###begin p 31
###xml 32 33 32 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 843 850 843 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 929 930 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
As presented in Additional file 1: table S1, males with the TC genotype of Val762Ala demonstrated a slightly reduced NHL risk (OR, 0.84; 95% CI, 0.60-1.16) compared to those with the TT genotype. And the males with the CC genotype had a significantly reduced risk (OR, 0.62; 95% CI, 0.41-0.93) which revealed a trend toward a gene dose effect (p for trend, 0.02). However, there was no association between Val762Ala polymorphism and NHL risk in females. There was significant interaction seen between sex and the Val762Ala polymorphism (p for interaction, 0.048). Asp81Asp (p for trend, 0.04) and Lys352Lys (p for trend, 0.03) polymorphisms revealed similar trends, although interactions between sex and polymorphism were a borderline significance levels (p for interaction of Asp81Asp, 0.062; p for interaction of Lys352Lys, 0.067). However, PARP-1 polymorphisms did not show associations with the NHL subtypes (Additional file 1: table S2) or age (data not shown).
###end p 31
###begin p 32
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
The distribution of PARP-1 haplotype frequencies and association of haplotypes with risk for NHL are summarized in Additional file 1: table S3. Three common haplotypes (ACAAC, GCGAT, and GTGGT) and several rare ones (with frequency < 5%) were inferred, and rare haplotypes were excluded in the association analyses. None of the haplotypes were associatied with overall risk for NHL. However the haplotype-ACAAC in males was associated with decreased risk for NHL (OR, 0.74; 95% CI, 0.59-0.94) when haplotype-GCGAT was used as a reference.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
We investigated the association between 5 PARP-1 polymorphisms and NHL risk in a Korean population. Three polymorphisms (Asp81Asp, Lys352Lys, and Val762Ala) were associated with decreased risk of NHL in males. A association testing of haplotype-ACAAC revealed a similar result. However, none of the PARP-1 polymorphisms or haplotypes were associated with overall NHL risk.
###end p 34
###begin p 35
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 493 501 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 534 543 <span type="species:ncbi:10090">nude mice</span>
Our data appear to support the hypothesis that accumulated DNA damage may lead to enhanced apoptosis during cell division, which could result in protection from development of malignancy with intact apoptotic mechanisms. Concordant findings with the results of this study have been identified in case-control studies of squamous cell carcinoma of the head and neck [15], breast carcinoma [18], and adult glioma [16]. In animal experiments, overexpression of dominant negative PARP-1 prevented in vivo tumor formation by HeLa cells in nude mice due to increased apoptosis of tumor cells [25].
###end p 35
###begin p 36
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 323 325 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 517 519 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 574 581 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 640 642 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 888 890 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 918 925 908 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 1000 1002 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 543 548 <span type="species:ncbi:10090">mouse</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 995 998 <span type="species:ncbi:9606">men</span>
PARP-1 polymorphisms were associated with decreased risk of NHL in males in this study. The sexual dimorphism might be associated with the female sex hormone, 17-beta-estradiol. PARP strongly interacts with estrogen receptor alpha and DNA in the presence of 17-beta-estradiol, which leads to inhibition of PARP activation [26]. Sex-dependent response to PARP activation has also been reported in an endotoxin-induced inflammation and vascular change model, female mice were more resistant to endotoxin than male mice[26]. In a neonatal-stroke mouse model, disruption of the PARP-1 gene selectively protected male mice against brain injury [27]. Also in an adult-stroke mouse model, female neuronal nitric oxide synthase knockout (nNOS-/-) mice were more severely damaged after middle cerebral artery occlusion than wild-type females. In addition, male nNOS-/- littermates were protected [28]. In a case-control study, PARP-1 polymorphism has been associated with reduced risk of adult glioma in men [16].
###end p 36
###begin p 37
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
Inconsistency of the association between PARP-1 polymorphism and malignancy risk might result from differences in genetic background, environmental factors, organ specificity, and study sample size. For example, the frequency of the Val762Ala genetic polymorphism differs between ethnic groups. In the present study of Koreans, the frequency of the C allele is 0.448 which is consistent with that observed in previous studies of Koreans (0.444) and Han Chinese (0.389) [12,29]. However, the frequency is 0.145 in Caucasian-Americans and 0.045 among African-Americans [8]. PARP-1 expression levels vary in carcinomas of different organs. It is high in lymphoma [30] and endometrial carcinoma [31], and low in breast carcinoma [32,33] and laryngeal carcinoma [34].
###end p 37
###begin p 38
In this present study, haplotype-ACAAC was also associated with reduced risk of NHL in males, although there was no association between any haplotypes and overall NHL risk. It agrees with the results that the A allele of Asp81Asp, A allele of Lys352Lys, and C allele of Val762Ala are significantly associated with decreased risk of NHL.
###end p 38
###begin p 39
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 365 372 365 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
As the sample size of this study is not sufficiently large and is restricted to Korean population, the present data should be validated in larger samples and in other ethnic groups. Although PARP-1 polymorphisms are associated with decreased risk of NHL in the present study, we could not exclude the possibility that other un-typed variants located in or near the PARP-1 locus might be associated with reduced risk of NHL. Additional surveys examining other variants around the locus are required to resolve this issue. A gene-gene interaction study examining genes involved in apoptosis or DNA repair might allow for a more comprehensive perspective.
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 95 102 95 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PARP-1 </italic>
In a polulation-based, case-control study to identify the association between polymorphisms in PARP-1 and NHL risk in Koreans, we found that Val762Ala, Asp81Asp, and Lys352Lys polymorphisms and the haplotype-ACAAC in PARP-1 were associated with decreased risk of NHL in males.
###end p 41
###begin title 42
Competing interests
###end title 42
###begin p 43
The authors declare that they have no competing interests.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
All authors read and approved the final version to be published. XMJ carried out genotyping and drafted the manuscript. HNK participated in sequence alignment. IKL involved in drafting the manuscript and revising it critically. KSP did statistical analysis of the data. HJK have given final approval of the version to be published. JSC collected the control samples and advised in data analysis. SWJ designed of the study. CC designed the study and helped to draft the manuscript.
###end p 45
###begin title 46
Pre-publication history
###end title 46
###begin p 47
The pre-publication history for this paper can be accessed here:
###end p 47
###begin p 48

###end p 48
###begin title 49
Supplementary Material
###end title 49
###begin title 50
Additional file 1
###end title 50
###begin p 51
Supplemental tables S1, S2 and S3.
###end p 51
###begin p 52
Click here for file
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN16-0005).
###end p 54
###begin article-title 55
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology
###end article-title 55
###begin article-title 56
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
###end article-title 56
###begin article-title 57
Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks
###end article-title 57
###begin article-title 58
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
###end article-title 58
###begin article-title 59
Genetic variation in the base excision repair pathway and bladder cancer risk
###end article-title 59
###begin article-title 60
Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma
###end article-title 60
###begin article-title 61
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function
###end article-title 61
###begin article-title 62
Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane
###end article-title 62
###begin article-title 63
Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation
###end article-title 63
###begin article-title 64
###xml 37 46 <span type="species:ncbi:210">H. pylori</span>
PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population
###end article-title 64
###begin article-title 65
Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer
###end article-title 65
###begin article-title 66
[Correlation of genetic polymorphisms in DNA repair genes ADPRT and XRCC1 to risk of gastric cancer]
###end article-title 66
###begin article-title 67
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice
###end article-title 67
###begin article-title 68
Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck
###end article-title 68
###begin article-title 69
Association and interactions between DNA repair gene polymorphisms and adult glioma
###end article-title 69
###begin article-title 70
Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia
###end article-title 70
###begin article-title 71
###xml 55 60 <span type="species:ncbi:9606">human</span>
Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk
###end article-title 71
###begin article-title 72
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease
###end article-title 72
###begin article-title 73
###xml 73 78 <span type="species:ncbi:9606">women</span>
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut
###end article-title 73
###begin article-title 74
Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma
###end article-title 74
###begin article-title 75
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
###end article-title 75
###begin article-title 76
High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain
###end article-title 76
###begin article-title 77
###xml 90 99 <span type="species:ncbi:10090">nude mice</span>
Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo
###end article-title 77
###begin article-title 78
Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation
###end article-title 78
###begin article-title 79
###xml 26 30 <span type="species:ncbi:10090">mice</span>
PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury
###end article-title 79
###begin article-title 80
Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection
###end article-title 80
###begin article-title 81
No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer
###end article-title 81
###begin article-title 82
Enhanced expression of poly(ADP-ribose) synthetase gene in malignant lymphoma
###end article-title 82
###begin article-title 83
Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors
###end article-title 83
###begin article-title 84
###xml 78 83 <span type="species:ncbi:9606">human</span>
Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer
###end article-title 84
###begin article-title 85
###xml 31 36 <span type="species:ncbi:9606">human</span>
Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis
###end article-title 85
###begin article-title 86
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Reduced poly(ADP-ribosyl)ation in lymphocytes of laryngeal cancer patients: results of a case-control study
###end article-title 86

